Dr Walley is Professor of Medicine and an addiction expert at Boston Medical Center and Boston University School of Medicine. Dr Walley has conducted multiple studies related to the opioid crisis and the integration of addiction specialty care and general medical care. He has served as PI on a CDC-SAMHSA-Epi-AID investigation of the surge in fentanyl-related overdose, a CDC-funded study of the Massachusetts OEND program which demonstrated community-level reductions in overdose death rates, and a SAMHSA-funded program that integrated addiction treatment into the clinical care of people with/at risk for HIV. He has worked as Co-I with addiction, overdose, and HIV expertise on NIDA and NIAAA-funded clinical trials and cohort studies.
Dr Walley is the director of the Boston Medical Center Addiction Medicine Fellowship program, as well as the director the NIDA-funded Fellow Immersion Training program in Addiction Medicine, which trains 5 subspecialty fellows each year to integrate addiction science into their subspecialty research. He provides primary care and addiction medicine consultations in the HIV primary care clinic at Boston University School of Medicine/BMC where he leads the FAST PATH (Facilitated Access to Substance abuse Treatment for Prevention and Treatment of HIV) program. Dr Walley co-founded and provides care on the inpatient addiction consult service at Boston Medical Center, which regularly provides consultation for patients admitted to the hospital who use alcohol and substances. Lastly, Dr Walley has been the medical director of the Massachusetts Opioid Overdose Prevention program since it started in 2007. They have trained and equipped over 100,000 people in the community with naloxone rescue kits, culminating in over 25,000 documented overdose rescues.
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University School of Medicine
- Courtesy Staff Privileges, Medicine, Boston Medical Center
- Johns Hopkins University School of Medicine, MD
- Boston University School of Public Health, MSc
- Harvard College, AB
- Published on 11/2/2021
Kimmel SD, Kim JH, Kalesan B, Samet JH, Walley AY, Larochelle MR. Against Medical Advice Discharges in Injection and Non-injection Drug Use-associated Infective Endocarditis: A Nationwide Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2484-e2492. PMID: 32756935.
- Published on 11/1/2021
Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, Saia KM, Costello E, Park TW, LaBelle C, Weinstein Z, Walley AY. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. J Addict Med. 2021 Nov-Dec 01; 15(6):448-451. PMID: 33298750.
- Published on 10/23/2021
Tori ME, Cummins E, Beletsky L, Schoenberger SF, Lambert AM, Yan S, Carroll JJ, Formica SW, Green TC, Apsler R, Xuan Z, Walley AY. Warrant checking practices by post-overdose outreach programs in Massachusetts: A mixed-methods study. Int J Drug Policy. 2021 Oct 23; 100:103483. PMID: 34700251.
- Published on 10/5/2021
Samet JH, Tsui JI, Cheng DM, Liebschutz JM, Lira MC, Walley AY, Colasanti JA, Forman LS, Root C, Shanahan CW, Sullivan MM, Bridden CL, Abrams C, Harris C, Outlaw K, Armstrong WS, Del Rio C. Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial. Clin Infect Dis. 2021 10 05; 73(7):e2052-e2058. PMID: 32697847.
- Published on 9/28/2021
Crable EL, Drainoni ML, Jones DK, Walley AY, Milton Hicks J. Predicting longitudinal service use for individuals with substance use disorders: A latent profile analysis. J Subst Abuse Treat. 2021 Sep 28; 108632. PMID: 34607732.
- Published on 9/22/2021
Braun HM, Jones EK, Walley AY, Siegel J, Streed CG. Characterizing Substance Use Disorders among Transgender Adults Receiving Care at a Large Urban Safety Net Hospital. J Addict Med. 2021 Sep 22. PMID: 34561349.
- Published on 9/2/2021
Zang X, Macmadu A, Krieger MS, Behrends CN, Green TC, Morgan JR, Murphy SM, Nolen S, Walley AY, Schackman BR, Marshall BD. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island. Int J Drug Policy. 2021 Sep 02; 98:103435. PMID: 34482264.
- Published on 8/29/2021
Harris MT, Seliga RK, Fairbairn N, Nolan S, Walley AY, Weinstein ZM, Turnbull J. Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing. Int J Drug Policy. 2021 Aug 29; 98:103400. PMID: 34469781.
- Published on 8/23/2021
Pollini RA, Slocum S, Ozga J, Joyce R, Xuan Z, Green TC, Walley AY. Pharmacists' experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study. J Am Pharm Assoc (2003). 2021 Aug 23. PMID: 34511372.
- Published on 6/1/2021
Kimmel S, Bach P, Walley AY. Treatment of Refractory Opioid Use Disorder : Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: A Narrative Review. J Gen Intern Med. 2021 06; 36(6):1793. PMID: 33772440.
View 153 more publications: View full profile at BUMC